WHO ICTRP trial
Adjuvant Therapy for Diabetes Mellitus-2
CTRI/2024/02/063063 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/02/063063 |
|---|---|
| Public title | Adjuvant Therapy for Diabetes Mellitus-2 |
| Scientific title | Mechanistic Investigation of TABATA Training as an Adjuvant Therapy in Type-2 Diabetes Management |
| Primary sponsor | Sharda University |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2/ Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: E119- Type 2 diabetes mellitus without complications |
| Interventions | Intervention1: Tabata Training: Total sets/day: 8 comprehensive sets Frequency of exercise: 4 times in a week Mode of Exercise: Tabata Training Ratio: 20:10 seconds Intervention: 20-s extreme focus work out (at 170% VO2max/Maximum heart… |
| Registration date | Feb 22, 2024 |
| Target size | 165 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: